Additional Information
Book Details
Abstract
Long respected as the most comprehensive nurse anesthesia resource available, this new edition continues the tradition of bringing together leading experts to create a balanced reference that applies scientific principles to today’s clinical anesthesia practice. Inside you’ll find a solid introduction to the equipment and patient care techniques unique to nurse anesthesia side-by-side with the cutting-edge research and application of evidence necessary to prepare you for tomorrow.
- Over 700 tables and boxes highlight the most essential information in a quick, easy-to-reference format.
- An easy-to-use organization with basic principles covered first, followed by individual chapters for each surgical specialty, ensures you have the information you need to build your knowledge.
- Over 650 figures of anatomy, nurse anesthesia procedures, and equipment enhance your understanding of complex information.
- Expert CRNA authors provide the most up-to-date and relevant clinical information you’ll use in daily practice.
- The latest pharmacology information on pharmacokinetics, drug delivery systems, opiate antagonists, and key induction drugs to keep you up-to-date.
- Thoroughly updated references make finding the latest and most important research in the field quick and simple.
- New chapters address legal issues, neonatal anesthesia, anesthesia education, clinical monitoring, regional anesthesia, unexpected complications, and more.
- Expanded coverage of chemistry and physics as well as immunology makes these difficult fundamental topics easier to understand and apply to everyday practice.
- Over 100 new images enhance your understanding of difficult anesthesia concepts.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Nurse Anesthesia | i | ||
Copyright Page | ii | ||
Table of Contents | xi | ||
Contributors | iii | ||
Preface | vii | ||
Acknowledgments | ix | ||
Unit I: Professional Issues | 1 | ||
Chapter 1. Nurse Anesthesia | 1 | ||
THE PERIOD OF THE FAILED PROMISE | 1 | ||
HISTORICAL BEGINNINGS OF THE NURSE ANESTHETIST | 2 | ||
ANESTHESIA: MEDICINE, NURSING, DENTISTRY, OR WHAT? | 4 | ||
ORGANIZATIONAL AND PROFESSIONAL SURVIVAL | 5 | ||
WORLD WAR II AND NURSE ANESTHETISTS | 6 | ||
A SHORT-LIVED PEACE FOR NURSE ANESTHETISTS AND THE NATION | 6 | ||
THE NEW AGE OF NURSE ANESTHESIA: THE 1960s | 8 | ||
AMERICAN ASSOCIATION OF NURSE ANESTHETISTS’ INCREASING FEDERAL INVOLVEMENT IN THE 1970s | 9 | ||
FEDERAL LEGISLATIVE INITIATIVES IN THE 1980s | 11 | ||
THE CALL FOR HEALTH-CARE REFORM IN THE 1990s | 16 | ||
ENDING THE 20TH CENTURY | 20 | ||
THE NEW MILLENNIUM BEGINS | 21 | ||
CRNA PRACTICE TODAY | 23 | ||
SUMMARY | 24 | ||
REFERENCES | 25 | ||
Chapter 2. Specialty Practice of Nurse Anesthesia | 28 | ||
THE CERTIFIED REGISTERED NURSE ANESTHETIST | 28 | ||
ROLE OF THE PROFESSIONAL ORGANIZATION | 30 | ||
SUMMARY | 32 | ||
REFERENCES | 32 | ||
Chapter 3. Nurse Anesthesia Education in the United States | 34 | ||
HISTORY OF NURSE ANESTHESIA EDUCATION | 34 | ||
THE PROFESSIONAL ORGANIZATION’S VISION FOR EDUCATION | 34 | ||
CHALLENGES FACING NURSE ANESTHESIA EDUCATION | 36 | ||
UPGRADING NURSE ANESTHESIA EDUCATIONAL REQUIREMENTS | 37 | ||
NURSE ANESTHESIA EDUCATION TODAY | 37 | ||
SUMMARY | 39 | ||
REFERENCES | 39 | ||
Chapter 4. Legal Issues in Nurse Anesthesia | 40 | ||
SOURCES OF LAW | 40 | ||
LEGAL AREAS OF INTEREST TO THE NURSE ANESTHETIST | 42 | ||
AVOIDING A LAWSUIT | 46 | ||
IF YOU ARE SUED | 47 | ||
SUMMARY | 48 | ||
REFERENCES | 48 | ||
Unit II: Scientific Foundations | 49 | ||
Chapter 5. Nurse Anesthesia Research | 49 | ||
WAYS OF KNOWING | 49 | ||
THE NATURE OF RESEARCH | 50 | ||
THE EIGHT CRITICAL STAGES IN THE RESEARCH PROCESS | 50 | ||
FRAUD, DECEIT, AND HUMAN ERROR IN SCIENTIFIC RESEARCH | 62 | ||
STUDIES INVOLVING HUMAN SUBJECTS | 62 | ||
CONTROVERSIES IN ANIMAL RESEARCH | 63 | ||
EVIDENCE-BASED PRACTICE: EMPOWERING DECISION MAKING THROUGH RESEARCH | 63 | ||
SUMMARY | 66 | ||
REFERENCES | 66 | ||
Chapter 6. General Principles, Pharmacodynamics, and Drug Receptor Concepts | 67 | ||
RECEPTOR STRUCTURE | 67 | ||
DRUG RESPONSE EQUATION | 69 | ||
POPULATION VARIABILITY | 69 | ||
DRUG DOSE RESPONSE | 70 | ||
DRUG RECEPTOR INTERACTIONS | 72 | ||
DRUG ANTAGONISM | 73 | ||
SUMMARY | 75 | ||
REFERENCES | 75 | ||
Chapter 7. Pharmacokinetics | 77 | ||
PROPERTIES THAT INFLUENCE PHARMACOKINETIC ACTIVITY | 77 | ||
OTHER FACTORS THAT INFLUENCE PHARMACOKINETICS | 89 | ||
PHARMACOGENETICS AND PHARMACOGENOMICS | 90 | ||
SUMMARY | 91 | ||
REFERENCES | 92 | ||
Chapter 8. Pharmacokinetics of Inhalation Anesthetics | 93 | ||
PRIMARY FACTORS CONTROLLING UPTAKE, DISTRIBUTION, AND ELIMINATION OF ANESTHETICS | 93 | ||
PEDIATRICS | 96 | ||
SUMMARY | 97 | ||
REFERENCES | 97 | ||
Chapter 9. Inhalation Anesthetics | 99 | ||
RELATIONSHIP OF CHEMICAL STRUCTURE AND AGENT CHARACTERISTICS | 99 | ||
METABOLISM | 100 | ||
PHARMACODYNAMICS | 101 | ||
MINIMUM ALVEOLAR CONCENTRATION | 102 | ||
INFLUENCE OF INHALATION AGENTS ON ORGANS AND SYSTEMS | 103 | ||
SUMMARY | 111 | ||
REFERENCES | 112 | ||
Chapter 10. Intravenous Induction Agents | 118 | ||
BARBITURATES | 118 | ||
NONBARBITURATE INTRAVENOUS ANESTHETICS | 126 | ||
BENZODIAZEPINES | 135 | ||
SUMMARY | 138 | ||
REFERENCES | 138 | ||
Chapter 11. Local Anesthetics | 142 | ||
ANATOMY OF THE PERIPHERAL NERVE | 142 | ||
NEURON ELECTROPHYSIOLOGY AND THE ACTION MECHANISM OF LOCAL ANESTHETICS | 142 | ||
CHEMICAL STRUCTURE OF LOCAL ANESTHETICS | 145 | ||
PHARMACODYNAMICS AND PHARMACOKINETIC CONCEPTS | 146 | ||
TOXICITY OF LOCAL ANESTHETICS | 153 | ||
NEWER LOCAL ANESTHETIC COMPOUNDS | 157 | ||
CLINICAL USE OF LOCAL ANESTHETICS | 159 | ||
SUMMARY | 161 | ||
REFERENCES | 161 | ||
Chapter 12. Opioid Agonists and Antagonists | 165 | ||
OPIOIDS | 165 | ||
CLASSIFICATION OF OPIOIDS | 171 | ||
CLINICAL USES OF OPIOIDS | 175 | ||
SUMMARY | 177 | ||
REFERENCES | 177 | ||
Chapter 13. Neuromuscular Blocking Agents, Reversal Agents, and Their Monitoring | 179 | ||
HISTORY | 179 | ||
MONITORING OF NEUROMUSCULAR BLOCKADE | 180 | ||
DEPOLARIZING AGENTS | 181 | ||
NONDEPOLARIZING AGENTS | 189 | ||
REVERSAL OF NEUROMUSCULAR BLOCKADE | 196 | ||
CHOLINESTERASE INHIBITORS | 196 | ||
ANTICHOLINERGICS | 198 | ||
SUMMARY | 199 | ||
REFERENCES | 200 | ||
Chapter 14. Autonomic and Cardiac Pharmacology | 203 | ||
AUTONOMIC DRUGS–SYMPATHOMIMETIC AMINES | 203 | ||
DIRECT-ACTING α-AGONISTS | 207 | ||
MIXED FUNCTION AGONISTS | 207 | ||
SELECTIVE β2-AGONISTS | 208 | ||
α-RECEPTOR ANTAGONISTS | 208 | ||
β-ADRENERGIC BLOCKING AGENTS | 210 | ||
CHOLINERGICS | 211 | ||
ANTICHOLINERGICS | 212 | ||
DIRECT VASODILATORS | 213 | ||
CALCIUM ANTAGONISTS | 215 | ||
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS | 218 | ||
ANGIOTENSIN II RECEPTOR ANTAGONISTS | 220 | ||
CATECHOLAMINE-DEPLETING AGENTS | 220 | ||
TYROSINE HYDROXYLASE INHIBITORS | 220 | ||
CATECHOL-O-METHYLTRANSFERASE INHIBITORS | 220 | ||
PHOSPHODIESTERASE III INHIBITORS | 220 | ||
CARDIAC GLYCOSIDES | 221 | ||
OTHER AGENTS | 221 | ||
MANAGEMENT OF SPECIFIC DISEASES | 221 | ||
PREOPERATIVE ADMINISTRATION OF CARDIAC DRUGS | 226 | ||
SUMMARY | 232 | ||
REFERENCES | 232 | ||
Chapter 15. Chemistry and Physics of Anesthesia | 235 | ||
ATOMIC STRUCTURE | 236 | ||
MOLECULAR BOND TYPES | 237 | ||
BOND BREAKING | 238 | ||
ORGANIC COMPOUNDS | 239 | ||
SOLUBILTY | 240 | ||
DIFFUSION | 240 | ||
GRAVITY | 241 | ||
NEWTON’S LAWS OF MOTION | 242 | ||
FORCE | 242 | ||
PRESSURE | 242 | ||
ENERGY | 245 | ||
ENTROPY | 245 | ||
TEMPERATURE | 245 | ||
KINETIC MOLECULAR THEORY | 247 | ||
GAS LAWS | 247 | ||
FLUID FLOW | 249 | ||
WAVES | 251 | ||
ELECTROMAGNETIC RADIATION | 256 | ||
ELECTROMAGNETIC RADIATION/MATTER INTERACTION | 256 | ||
RADIOGRAPHY | 257 | ||
GAS ANALYSIS | 257 | ||
PULSE OXIMETRY | 261 | ||
LASERS | 262 | ||
SUMMARY | 263 | ||
REFERENCES | 263 | ||
Unit III: Technology Related to Anesthesia Practice | 266 | ||
Chapter 16. Anesthesia Equipment | 266 | ||
ORGANIZATION OF THE ANESTHESIA GAS MACHINE | 266 | ||
SUPPLY | 267 | ||
PROCESSING | 275 | ||
DELIVERY | 290 | ||
DISPOSAL | 307 | ||
RISK MANAGEMENT | 308 | ||
SUMMARY | 310 | ||
REFERENCES | 310 | ||
Chapter 17. Clinical Monitoring I: Cardiovascular System | 315 | ||
PULMONARY ARTERY CATHETERIZATION | 315 | ||
AUTOMATED ST-SEGMENT MONITORING | 323 | ||
ARTERIAL PRESSURE MONITORING | 329 | ||
TRANSESOPHAGEAL ECHOCARDIOGRAPHY MONITORING | 331 | ||
SUMMARY | 333 | ||
REFERENCES | 334 | ||
Chapter 18. Clinical Monitoring II: Respiratory and Metabolic Systems | 337 | ||
MONITORING STANDARDS | 337 | ||
PRACTICAL APPROACH TO MONITORING | 337 | ||
ADDITIONAL MONITORING ISSUES | 345 | ||
ANESTHESIA EDUCATION AND PATIENT MONITORING | 345 | ||
FUTURE OF CLINICAL MONITORING | 346 | ||
SUMMARY | 346 | ||
REFERENCES | 346 | ||
Chapter 19. Clinical Monitoring III: Neurologic System | 348 | ||
ELECTROENCEPHALOGRAM | 348 | ||
PROCESSED EEG WAVEFORMS | 350 | ||
EVOKED POTENTIALS | 353 | ||
SUMMARY | 356 | ||
REFERENCES | 356 | ||
Unit IV: Preoperative Preparation | 358 | ||
Chapter 20. Preoperative Evaluation and Preparation of the Patient | 358 | ||
PREANESTHESIA ASSESSMENT CLINIC | 358 | ||
CHART REVIEW | 359 | ||
PATIENT INTERVIEW | 360 | ||
PATIENT EVALUATION: OVERVIEW OF SYSTEMS | 368 | ||
DIAGNOSTIC TESTING | 391 | ||
FASTING CONSIDERATIONS | 392 | ||
AMERICAN SOCIETY OF ANESTHESIOLOGISTS PHYSICAL STATUS CLASSIFICATION SYSTEM | 394 | ||
PREVENTING OPERATIVE ERRORS | 395 | ||
SUMMARY | 395 | ||
REFERENCES | 397 | ||
Unit V: Intraoperative Management | 401 | ||
Chapter 21. Fluids, Electrolytes, and Blood Component Therapy | 401 | ||
FLUID COMPARTMENTS | 401 | ||
INFLUENCES OF SURGERY AND ANESTHESIA ON FLUID BALANCE | 401 | ||
FLUID VOLUME DISORDERS | 403 | ||
DISORDERS OF SODIUM BALANCE | 403 | ||
DISORDERS OF POTASSIUM BALANCE | 406 | ||
DISORDERS OF CALCIUM BALANCE | 408 | ||
DISORDERS OF MAGNESIUM BALANCE | 410 | ||
PARENTERAL FLUIDS | 410 | ||
BLOOD COMPONENT THERAPY | 413 | ||
SUMMARY | 417 | ||
REFERENCES | 418 | ||
Chapter 22. Positioning for Anesthesia and Surgery | 420 | ||
CLOSED-CLAIMS STUDIES | 420 | ||
PATHOPHYSIOLOGY OF NERVE INJURY | 421 | ||
PERIOPERATIVE FACTORS CONTRIBUTING TO NERVE INJURIES | 422 | ||
PATIENT-RELATED FACTORS CONTRIBUTING TO NERVE INJURIES | 422 | ||
PERIOPERATIVE NEUROPATHIES | 423 | ||
BRACHIAL PLEXUS INJURIES | 424 | ||
SPINAL CORD INJURY | 425 | ||
POSTOPERATIVE VISUAL LOSS | 426 | ||
OTHER POSITION-RELATED INJURIES | 427 | ||
SURGICAL POSITIONING | 429 | ||
PHYSIOLOGIC EFFECTS OF SURGICAL POSITIONS | 434 | ||
SUMMARY | 437 | ||
REFERENCES | 437 | ||
Chapter 23. Airway Management | 441 | ||
ANATOMY AND PHYSIOLOGY OF THE AIRWAY | 441 | ||
AIRWAY ASSESSMENT | 444 | ||
TRACHEAL INTUBATION | 445 | ||
AIRWAY BLOCKS | 451 | ||
CRICOID PRESSURE | 452 | ||
ADJUNCT AIRWAY EQUIPMENT AND TECHNIQUES | 452 | ||
COMPLICATIONS OF TRACHEAL INTUBATION | 460 | ||
DIFFICULT AIRWAY IN OBSTETRIC ANESTHESIA | 462 | ||
SUMMARY | 463 | ||
REFERENCES | 463 | ||
Chapter 24. Cardiovascular Anatomy, Physiology, Pathophysiology, and Anesthesia Management | 465 | ||
CARDIOVASCULAR SYSTEM | 465 | ||
CARDIOVASCULAR REFLEXES | 479 | ||
VASCULAR SYSTEM | 480 | ||
HYPERTENSION | 487 | ||
MITRAL STENOSIS | 494 | ||
MITRAL REGURGITATION AND INSUFFICIENCY | 495 | ||
AORTIC STENOSIS | 497 | ||
AORTIC INSUFFICIENCY | 499 | ||
HYPERTROPHIC CARDIOMYOPATHY | 500 | ||
MITRAL VALVE PROLAPSE | 501 | ||
SUMMARY | 502 | ||
REFERENCES | 502 | ||
Chapter 25. Anesthesia for Cardiac Surgery | 504 | ||
CORONARY ARTERY DISEASE | 504 | ||
EFFECTS OF CARDIOPULMONARY BYPASS | 504 | ||
ANESTHESIA CONSIDERATIONS | 506 | ||
ANESTHESIA MONITORING | 510 | ||
PERFUSION PRINCIPLES | 511 | ||
COAGULATION | 513 | ||
PROPHYLAXIS AND TREATMENT OF COAGULOPATHY | 514 | ||
PHARMACOLOGIC APPROACHES TO BLOOD PRESSURE CONTROL | 515 | ||
PREOPERATIVE PERIOD | 515 | ||
INTRAOPERATIVE PERIOD | 516 | ||
DISCONTINUING CARDIOPULMONARY BYPASS | 517 | ||
MANAGEMENT OF COMPLICATIONS OF CARDIAC BYPASS | 519 | ||
EXTUBATION | 521 | ||
UNIQUE SITUATIONS IN CARDIAC ANESTHESIA | 521 | ||
MINIMALLY INVASIVE CORONARY ARTERY BYPASS TECHNIQUES | 522 | ||
ABLATION PROCEDURES | 523 | ||
PEDIATRIC APPROACHES | 524 | ||
SUMMARY | 525 | ||
REFERENCES | 525 | ||
Chapter 26. Anesthesia for Vascular Surgery | 528 | ||
PERIPHERAL VASCULAR DISEASE | 528 | ||
ABDOMINAL AORTIC ANEURYSMS | 530 | ||
ABDOMINAL AORTIC RECONSTRUCTION | 530 | ||
THORACIC AORTIC ANEURYSMS | 538 | ||
AORTIC DISSECTION | 539 | ||
DESCENDING THORACIC AND THORACOABDOMINAL ANEURYSMS | 540 | ||
ENDOVASCULAR AORTIC ANEURYSM REPAIR | 543 | ||
CEREBROVASCULAR INSUFFICIENCY AND CAROTID ENDARTERECTOMY | 546 | ||
CAROTID ARTERY STENTING | 552 | ||
PERIOPERATIVE COST CONTAINMENT | 554 | ||
SUMMARY | 555 | ||
REFERENCES | 555 | ||
Chapter 27. Respiratory Anatomy, Physiology, Pathophysiology, and Anesthesia Management | 560 | ||
ANATOMY OF THE RESPIRATORY SYSTEM | 560 | ||
MECHANICS OF BREATHING | 565 | ||
PULMONARY BLOOD FLOW | 570 | ||
ACID-BASE BALANCE | 575 | ||
TREATMENT OF BLOOD GAS ABNORMALITIES | 577 | ||
CONTROL OF BREATHING | 577 | ||
CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 578 | ||
ASTHMA | 587 | ||
PULMONARY HYPERTENSION | 593 | ||
COR PULMONALE | 594 | ||
PULMONARY EMBOLISM | 597 | ||
RESTRICTIVE PULMONARY DISEASES | 603 | ||
ASPIRATION PNEUMONITIS | 605 | ||
ACUTE RESPIRATORY DISTRESS SYNDROME | 610 | ||
NONCYTOTOXIC AND CYTOTOXIC DRUG-INDUCED PULMONARY DISEASE | 612 | ||
PULMONARY OXYGEN TOXICITY | 615 | ||
AUTOIMMUNE DISORDERS | 616 | ||
FLAIL CHEST | 618 | ||
PNEUMOTHORAX | 618 | ||
ATELECTASIS | 620 | ||
PLEURAL EFFUSION | 621 | ||
SKELETAL DISORDERS | 621 | ||
SUMMARY | 625 | ||
REFERENCES | 625 | ||
Chapter 28. Anesthesia for Thoracic Surgery | 630 | ||
PREOPERATIVE PREPARATION | 630 | ||
LATERAL DECUBITUS POSITION | 634 | ||
ONE-LUNG VENTILATION | 636 | ||
ANALGESIA FOR THORACIC SURGERY | 644 | ||
COMPLICATIONS AFTER THORACOTOMY | 644 | ||
MEDIASTINAL MASSES | 645 | ||
BULLAE | 647 | ||
SUMMARY | 648 | ||
REFERENCES | 648 | ||
Chapter 29. Neuroanatomy, Neurophysiology, and Neuroanesthesia | 651 | ||
ORGANIZATION OF THE CENTRAL NERVOUS SYSTEM | 651 | ||
ANATOMY OF THE CENTRAL NERVOUS SYSTEM | 653 | ||
PERIPHERAL NERVOUS SYSTEM | 656 | ||
VASCULATURE OF THE CENTRAL NERVOUS SYSTEM | 658 | ||
ELECTROPHYSIOLOGY | 659 | ||
NEUROTRANSMITTERS | 660 | ||
SENSORY PATHWAYS | 662 | ||
MOTOR PATHWAYS | 664 | ||
NEUROANESTHESIA | 667 | ||
INTRACRANIAL PRESSURE | 670 | ||
NEUROPHYSIOLOGIC MONITORING | 673 | ||
ANESTHETIC CONSIDERATIONS FOR SPECIFIC PROCEDURES | 674 | ||
SUMMARY | 690 | ||
REFERENCES | 690 | ||
Chapter 30. Renal Anatomy, Physiology, Pathophysiology, and Anesthesia Management | 694 | ||
STRUCTURE OF THE KIDNEY | 694 | ||
RENAL PHYSIOLOGY | 696 | ||
EFFECTS OF ANESTHESIA ON NORMAL RENAL FUNCTION | 700 | ||
ACUTE RENAL FAILURE | 702 | ||
CHRONIC RENAL FAILURE | 705 | ||
PREOPERATIVE RENAL ASSESSMENT | 706 | ||
ANESTHETIC MANAGEMENT OF PATIENTS WITH ADVANCED RENAL DISEASE | 710 | ||
INTRAVENOUS FLUID MANAGEMENT | 713 | ||
ANESTHESIA FOR RENAL TRANSPLANTATION | 714 | ||
EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY | 718 | ||
PERCUTANEOUS NEPHROLITHOTOMY | 719 | ||
TRANSURETHRAL RESECTION OF THE PROSTATE | 719 | ||
LAPAROSCOPIC UROLOGIC SURGERY | 721 | ||
ROBOTIC UROLOGIC SURGERY | 722 | ||
SUMMARY | 722 | ||
REFERENCES | 722 | ||
Chapter 31. Hepatobiliary and Gastrointestinal Disturbances and Anesthesia | 727 | ||
PANCREATIC DISEASE | 727 | ||
LIVER DISEASE | 730 | ||
SURGICAL DECOMPRESSION PROCEDURES | 740 | ||
DISEASES OF THE BILIARY TRACT | 741 | ||
DISEASES OF THE ESOPHAGUS | 744 | ||
DISEASES OF THE STOMACH | 746 | ||
PERITONEUM | 750 | ||
DISEASES OF THE INTESTINAL TRACT | 751 | ||
SPLENIC DISEASE | 759 | ||
CARCINOID TUMORS AND CARCINOID SYNDROME | 760 | ||
TRANSPLANTATION | 762 | ||
SUMMARY | 769 | ||
REFERENCES | 769 | ||
Chapter 32. Anesthesia for Laparoscopic Surgery | 771 | ||
CREATION OF THE PNEUMOPERITONEUM | 771 | ||
COMPLICATIONS OF LAPAROSCOPIC SURGERY | 772 | ||
PHYSIOLOGIC EFFECTS OF PNEUMOPERITONEUM | 773 | ||
ANESTHETIC MANAGEMENT | 776 | ||
POSTOPERATIVE CONSIDERATIONS | 777 | ||
THE FUTURE OF LAPAROSCOPIC SURGERY | 778 | ||
SUMMARY | 778 | ||
REFERENCES | 778 | ||
Chapter 33. Musculoskeletal System Anatomy, Physiology, Pathophysiology, and Anesthesia Management | 780 | ||
OVERVIEW OF NEUROMUSCULAR TRANSMISSION | 780 | ||
MUSCLE PHYSIOLOGY | 785 | ||
MUSCULOSKELETAL PATHOPHYSIOLOGY AND ANESTHESIA | 789 | ||
SUMMARY | 799 | ||
REFERENCES | 799 | ||
Chapter 34. The Endocrine System and Anesthesia | 802 | ||
GENERAL PRINCIPLES OF ENDOCRINE PHYSIOLOGY | 802 | ||
PITUITARY GLAND | 803 | ||
PARATHYROID GLAND | 809 | ||
PANCREAS | 813 | ||
DIABETES MELLITUS | 816 | ||
ADRENAL GLANDS | 823 | ||
THYROID GLAND | 834 | ||
SUMMARY | 839 | ||
REFERENCES | 839 | ||
Chapter 35. Hematology and Anesthesia | 842 | ||
THE NORMAL VESSEL WALL | 842 | ||
VESSEL INJURY | 843 | ||
CELL-BASED THEORY OF COAGULATION | 846 | ||
FIBRINLOYTIC SYSTEM | 846 | ||
ANESTHETIC IMPLICATIONS | 847 | ||
SPECIFIC DISORDERS | 853 | ||
OTHER CONSIDERATIONS | 854 | ||
SUMMARY | 860 | ||
REFERENCES | 860 | ||
Chapter 36. Thermal Injury and Anesthesia | 862 | ||
CLASSIFICATION OF BURN INJURY | 862 | ||
ETIOLOGIES OF BURN INJURIES | 862 | ||
TREATMENT OF THE BURN PATIENT | 864 | ||
SUMMARY | 873 | ||
REFERENCES | 873 | ||
Chapter 37. Trauma Anesthesia | 875 | ||
PATHOPHYSIOLOGIC CHANGES ARISING FROM TRAUMATIC INJURY | 875 | ||
CHARACTERISTICS OF TRAUMA PATIENTS | 876 | ||
IDEAL TRAUMA CARE | 876 | ||
TRAUMA SYSTEMS AND LEVELS OF CARE | 877 | ||
STAGES IN TRAUMA CARE | 877 | ||
TRAUMA-INDUCED SHOCK | 880 | ||
MECHANISM OF INJURY | 882 | ||
SELECTION OF ANESTHETIC AGENTS FOR THE TRAUMA PATIENT | 889 | ||
SUMMARY | 890 | ||
REFERENCES | 890 | ||
Chapter 38. Outpatient Anesthesia | 892 | ||
FEATURES OF OUTPATIENT SURGERY | 892 | ||
PATIENT SELECTION | 893 | ||
PATIENT EVALUATION AND PREPARATION | 896 | ||
PREMEDICATION | 901 | ||
ANESTHETIC CONSIDERATIONS | 902 | ||
POSTOPERATIVE CONSIDERATIONS | 906 | ||
SUMMARY | 913 | ||
REFERENCES | 914 | ||
Chapter 39. Anesthesia for Ear, Nose, Throat, and Maxillofacial Surgery | 921 | ||
FUNCTIONAL ANATOMY OF THE HEAD AND NECK | 921 | ||
PREPARATION AND CONSIDERATIONS FOR EAR, NOSE, AND THROAT PROCEDURES | 923 | ||
SPECIALIZED EQUIPMENT FOR EAR, NOSE, AND THROAT PROCEDURES | 926 | ||
SPECIAL CONSIDERATIONS FOR EAR, NOSE, AND THROAT PROCEDURES | 928 | ||
SELECT TECHNIQUES COMMONLY USED IN EAR, NOSE, AND THROAT PROCEDURES | 930 | ||
PROCEDURES OF THE EAR AND FACE | 934 | ||
SUMMARY | 939 | ||
REFERENCES | 940 | ||
Chapter 40. Anesthesia for Ophthalmic Procedures | 942 | ||
OPHTHALMIC ANATOMY | 942 | ||
PHARMACOLOGY: OCULAR MEDICATIONS AND ANESTHETIC AGENTS | 948 | ||
SELECT OCULAR ANESTHESIA TECHNIQUES | 952 | ||
OCULAR REGIONAL ANESTHESIA | 952 | ||
POSITIVE ORBITAL PRESSURE | 959 | ||
ANESTHESIA MANAGEMENT | 959 | ||
OPHTHALMIC ANESTHESIA COMPLICATIONS | 963 | ||
SUMMARY | 966 | ||
REFERENCES | 966 | ||
Chapter 41. Anesthesia for Orthopedics and Podiatry | 969 | ||
PNEUMATIC TOURNIQUET | 969 | ||
PATIENT POSITIONING | 971 | ||
ARTHROSCOPY | 973 | ||
ARTHROPLASTY | 976 | ||
SPINAL SURGERY | 978 | ||
FOOT AND ANKLE SURGERY | 981 | ||
FOREARM AND HAND SURGERY | 981 | ||
ARTHRITIC SYNDROMES | 981 | ||
SUMMARY | 982 | ||
REFERENCES | 982 | ||
Chapter 42. The Immune System and Anesthesia | 985 | ||
THE IMMUNE SYSTEM | 985 | ||
IMMUNE SYSTEM PATHOLOGY | 993 | ||
DISEASES OF THE IMMUNE SYSTEM | 997 | ||
ANESTHESIA AND THE IMMUNE SYSTEM | 1002 | ||
SUMMARY | 1006 | ||
REFERENCES | 1006 | ||
Chapter 43. Anesthesia and Laser Surgery | 1009 | ||
BASIC PRINCIPLES OF LASERS | 1009 | ||
MEDICAL LASERS | 1012 | ||
LASER SAFETY | 1015 | ||
LASER HAZARDS AND PRECAUTIONS | 1016 | ||
SPECIAL ANESTHETIC CONSIDERATIONS | 1021 | ||
ANESTHESIA FOR LASER PROCEDURES | 1021 | ||
SUMMARY | 1022 | ||
REFERENCES | 1022 | ||
Chapter 44. Obesity and Anesthesia Practice | 1024 | ||
OVERVIEW | 1024 | ||
ADIPOSE TISSUE | 1025 | ||
CAUSES OF OBESITY | 1027 | ||
PATHOPHYSIOLOGY OF OBESITY | 1027 | ||
PEDIATRIC OBESITY | 1030 | ||
MATERNAL OBESITY | 1031 | ||
TREATMENT OF OBESITY | 1031 | ||
PHARMACOLOGIC CONSIDERATIONS | 1032 | ||
ANESTHETIC MANAGEMENT: PREANESTHETIC EVALUATION | 1034 | ||
ANESTHETIC MANAGEMENT: PREPARATION | 1036 | ||
ANESTHETIC MANAGEMENT: MAINTENANCE | 1038 | ||
ANESTHETIC MANAGEMENT: POSTOPERATIVE CARE | 1040 | ||
SUMMARY | 1041 | ||
REFERENCES | 1041 | ||
Chapter 45. Regional Anesthesia: | 1045 | ||
APPLIED ANATOMY AND PHYSIOLOGY OF THE CENTRAL NEURAXIS | 1045 | ||
SPINAL ANESTHESIA | 1054 | ||
EPIDURAL ANESTHESIA | 1063 | ||
COMBINED SPINAL AND EPIDURAL ANESTHESIA | 1070 | ||
CAUDAL ANESTHESIA | 1073 | ||
SUMMARY | 1074 | ||
REFERENCES | 1074 | ||
Chapter 46. Regional Anesthesia: | 1077 | ||
HISTORY OF REGIONAL ANESTHESIA | 1077 | ||
SELECTION OF REGIONAL ANESTHESIA TECHNIQUES | 1077 | ||
COMPLICATIONS OF REGIONAL ANESTHESIA | 1079 | ||
PHARMACOLOGY OF LOCAL ANESTHETICS | 1080 | ||
ELECTRICAL STIMULATORS IN REGIONAL ANESTHESIA | 1083 | ||
ULTRASOUND-GUIDED REGIONAL ANESTHESIA | 1084 | ||
UPPER-EXTREMITY BLOCK | 1084 | ||
INTRAVENOUS REGIONAL ANESTHESIA (BIER BLOCK) | 1092 | ||
INTERCOSTAL NERVE BLOCKS | 1093 | ||
LOWER-EXTREMITY BLOCK | 1095 | ||
REGIONAL ANESTHESIA AND TRAUMA | 1101 | ||
SUMMARY | 1101 | ||
REFERENCES | 1102 | ||
Chapter 47. Obstetric Anesthesia | 1103 | ||
ANATOMIC AND PHYSIOLOGIC CHANGES DURING NORMAL PREGNANCY | 1103 | ||
STAGES OF LABOR AND DELIVERY | 1107 | ||
PREPARATION FOR ANESTHETIC INTERVENTION | 1109 | ||
INTRAVENOUS ANALGESIA IN THE PARTURIENT | 1114 | ||
REGIONAL ANALGESIA AND ANESTHESIA FOR LABOR AND VAGINAL DELIVERY | 1115 | ||
SURGICAL CONSIDERATIONS AND COMPLICATIONS FOR OBSTETRIC PATIENTS | 1121 | ||
ANESTHESIA FOR CESAREAN SECTION | 1124 | ||
ANESTHETIC COMPLICATIONS | 1126 | ||
OBSTETRIC COMPLICATIONS | 1129 | ||
ANESTHESIA FOR THE PREGNANT PATIENT UNDERGOING A NONOBSTETRIC PROCEDURE | 1139 | ||
NEONATAL RESUSCITATION | 1140 | ||
SUMMARY | 1140 | ||
REFERENCES | 1142 | ||
Chapter 48. Neonatal Anesthesia | 1147 | ||
DEVELOPMENTAL CONSIDERATIONS | 1147 | ||
GROWTH AND DEVELOPMENT | 1148 | ||
ANESTHETIC PHARMACOLOGIC CONSIDERATIONS IN THE NEONATE | 1154 | ||
DRUGS USED IN NEONATAL ANESTHESIA | 1155 | ||
FLUID MANAGEMENT | 1156 | ||
ANESTHETIC EQUIPMENT | 1159 | ||
PREOPERATIVE ASSESSMENT | 1160 | ||
ANESTHETIC CONSIDERATIONS FOR SELECTED CASES | 1165 | ||
SUMMARY | 1171 | ||
REFERENCES | 1171 | ||
Chapter 49. Pediatric Anesthesia | 1174 | ||
PEDIATRIC ANESTHETIC MORBIDITY AND MORTALITY | 1174 | ||
PEDIATRIC PHARMACOLOGIC CONSIDERATIONS | 1175 | ||
PERIOPERATIVE CARE | 1182 | ||
PREOPERATIVE PREPARATION | 1188 | ||
PEDIATRIC AIRWAY MANAGEMENT | 1196 | ||
INTRAVENOUS FLUID AND BLOOD THERAPY | 1201 | ||
PEDIATRIC REGIONAL ANESTHESIA | 1205 | ||
SUMMARY | 1206 | ||
REFERENCES | 1206 | ||
Chapter 50. Geriatrics and Anesthesia Practice | 1210 | ||
PERSPECTIVES ON AGING | 1210 | ||
EXPECTED ANATOMIC AND PHYSIOLOGIC CHANGES | 1210 | ||
PHARMACOKINETIC AND PHARMACODYNAMIC CONSIDERATIONS | 1214 | ||
PREOPERATIVE ASSESSMENT | 1215 | ||
ANESTHETIC MANAGEMENT | 1215 | ||
SUMMARY | 1217 | ||
REFERENCES | 1217 | ||
Chapter 51. Postanesthesia Recovery | 1218 | ||
POSTANESTHESIA CARE UNIT ADMISSION | 1218 | ||
ANESTHESIA REPORT | 1218 | ||
INITIAL POSTANESTHESIA CARE UNIT ASSESSMENT | 1218 | ||
ONGOING ASSESSMENT | 1220 | ||
DISCHARGE FROM THE POSTANESTHESIA CARE UNIT | 1234 | ||
SUMMARY | 1236 | ||
REFERENCES | 1237 | ||
Chapter 52. Pain Management | 1239 | ||
PAIN | 1240 | ||
ACUTE PAIN MANAGEMENT | 1243 | ||
DRUGS USED IN PAIN MANAGEMENT | 1244 | ||
MODE OF ADMINISTRATION | 1250 | ||
PAIN MANAGEMENT IN CHILDREN | 1256 | ||
CANCER-RELATED PAIN | 1257 | ||
SUMMARY | 1265 | ||
REFERENCES | 1265 | ||
Chapter 53. Anesthesia for Therapeutic and Diagnostic Procedures | 1268 | ||
ADMINISTRATION OF ANESTHESIA IN REMOTE LOCATIONS | 1268 | ||
ANESTHESIA FOR SPECIFIC PROCEDURES IN REMOTE LOCATIONS | 1279 | ||
REMOTE ANESTHETIC MONITORING USING TELECOMMUNICATIONS TECHNOLOGY | 1297 | ||
MORBIDITY AND MORTALITY RELATED TO THERAPEUTIC AND DIAGNOSTIC PROCEDURES | 1297 | ||
SUMMARY | 1297 | ||
ACKNOWLEDGMENTS | 1297 | ||
REFERENCES | 1297 | ||
Chapter 54. Anesthesia Complications | 1302 | ||
EYE INJURY | 1302 | ||
CARDIOPULMONARY COMPLICATIONS | 1304 | ||
COGNITIVE IMPAIRMENT | 1311 | ||
OPERATING ROOM FIRE | 1313 | ||
SUMMARY | 1314 | ||
REFERENCES | 1315 | ||
Index | 1319 |